Introduction Therapeutic advances in drug therapy of chronic obstructive pulmonary disease
(COPD) really effective in suppressing the pathological processes underlying the disease …

SUMMARY OF KEY POINTS International respiratory organizations now recommend using
lower limit of normal and standardized residuals to diagnose airflow obstruction and COPD …

Accurate and consistent assessments of cough are essential to advance the understanding
of the mechanisms of cough and individualised the management of patients. Considerable …

Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by
airway limitation and changes in airway structure. It has a high global burden of mortality …

The inhaled route is critical for the administration of drugs to treat patients suffering from
COPD, but there is still an unmet need for new and innovative inhalers to address some …

Introduction Strong scientific evidence and large experience support the use of β2-agonists
for the symptomatic alleviation of COPD. Therefore, there is considerable effort in …

Objectives To investigate the clinical efficacy and safety of bronchial thermoplasty (BT) in
treating patients with chronic obstructive pulmonary disease (COPD). Methods Clinical data …

Introduction Chronic obstructive pulmonary disease (COPD) is a prevalent disease of the
airways in which inhaled bronchodilators can be given as monotherapy or fixed dose …

那伐芬特罗(navafenterol) 是一单分子且同时具备毒蕈碱受体拮抗和β2 受体激动效应的新型
化合物, 正开发用于治疗慢性阻塞性肺疾病和哮喘等慢性阻塞气道疾病. 该药可显著改善肺功能 …

Navafenterol is a new compound with both muscarinic receptor antagonist and β2 receptor
agonist effects in a single molecule, who is being developed for the treatment of chronic …